Latest Hypoxia-inducible factors Stories
Most Nephrologists Believe There Is Some Level of Unmet Need for ESAs in CKD-ND and Dialysis Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
Half of Surveyed Nephrologists Were Aware that the FDA had Approved American Regent's IV Iron Injectafer, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
Offers Potential New Therapy for Difficult-to-Treat Triple Negative Breast Cancer Philadelphia, PA (PRWEB) May 22, 2014 A study from the Department of
CAMBRIDGE, Mass., March 18, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals,
CAMBRIDGE, Mass., Feb.
CAMBRIDGE, Mass., Jan.